InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Cohen Joshua B, Chairman & CEO. Director active across 1 company, notably Amylyx Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. Activity tracked since 6 January 2022. The latest transaction was disclosed on 5 May 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
334,520 shares@ US$0.370.0080% mcap100.0% of flowCommon StockSEC:0000899243-22-017083:0
4,870 shares0Common StockSEC:0000899243-22-001518
4,870 shares0Common StockSEC:0000899243-22-001518:0
3 of 3 declarations
About Cohen Joshua B
Joshua B. Cohen is the Co-Chief Executive Officer of Amylyx Pharmaceuticals, Inc. He shares responsibility for the strategic direction of the company, overseeing operations and development initiatives. Cohen brings expertise in the pharmaceutical sector, contributing to innovation and growth at Amylyx.
